FHOD3 and hypertrophic cardiomyopathy: Finally, a human genome analysis revealed that human mutations in Fhod3 indeed cause hypertrophic cardiomyopathy (Ochoa et al., 2018), indicating the critical role of Fhod3 in cardiac muscle.